July 22, 2026 — The American Society for Radiation Oncology (ASTRO) has announced the 39 members who will receive the ASTRO Fellow (FASTRO) designation this year. This honor recognizes ASTRO members’ outstanding achievements and contributions to the Society, cancer research, education, patient care and the specialty. The new Fellows will be recognized at ASTRO’s 68th Annual Meeting in Boston in September.
The FASTRO designation recognizes sustained achievement and service to ASTRO, the field of radiation oncology and patient care. First awarded in 2006, the designation has been awarded to just 580 of ASTRO’s more than 10,000 members worldwide. The incoming class of Fellows includes physicians, medical physicists and scientists whose work has advanced the science and delivery of radiation therapy for people with cancer and other diseases.
“The 2026 ASTRO Fellows reflect the depth and breadth of leadership in radiation medicine,” said ASTRO CEO Vivek S. Kavadi, MD, MBA, FASTRO. “Their careers demonstrate the many ways ASTRO members move our field forward through discovery, clinical excellence, education, mentorship and service. We are proud to recognize this distinguished class.”
2026 ASTRO Fellows
The 2026 Fellows are:
-
Michelle Alonso-Basanta, MD, PhD, University of Pennsylvania
-
Smith Apisarnthanarax, MD, University of Washington/Fred Hutchinson Cancer Center
-
Richard Bakst, MD, Icahn School of Medicine at Mount Sinai
-
Christopher Barker, MD, Memorial Sloan Kettering Cancer Center
-
Carmen Bergom, MD, PhD, Washington University School of Medicine
-
Melisa Boersma, MD, The University of Kansas Cancer Center/KUMC/TUKHS
-
Stuart Burri, MD, Southeast Radiation Oncology Group
-
Jimmy Caudell, MD, PhD, Moffitt Cancer Center
-
Luqman Dad, MD, MBA, Maryland Oncology Hematology
-
Parima Daroui, MD, PhD, City of Hope National Medical Center
-
Issam El Naqa, PhD, Moffitt Cancer Center & Research Institute
-
Ralph Ermoian, MD, University of Washington
-
Steven Finkelstein, MD, Associated Medical Professionals (AMP)/USUP
-
Daphna Gelblum, MD, Memorial Sloan Kettering Cancer Center
-
Lia Halasz, MD, University of Washington
-
Matthew Harkenrider, MD, Loyola University Medical Center
-
Ariel Hirsch, MD, Boston University Chobanian and Avedisian School of Medicine
-
Krisha Howell, MD, MHP Radiation Oncology Institute
-
Candice Johnstone, MD, MPH, Medical College of Wisconsin
-
Mitchell Kamrava, MD, Cedars-Sinai Medical Center
-
Alexander Louie, MD, PhD, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto
-
Michelle Ludwig, MD, PhD, MPH, University of Colorado Anschutz
-
Danielle Margalit, MD, MPH, Dana-Farber Brigham Cancer Center
-
David Marshall, MD, Medical University of South Carolina
-
Malcolm Mattes, MD, Rutgers Cancer Institute
-
Martha Matuszak, PhD, University of Michigan
-
Rosalyn Morrell, MD, Beverly Hills Cancer Center
-
Shannon Offerman, MD, Radiation Oncology Associates, Ltd.
-
Manisha Palta, MD, Duke University
-
Chelsea Pinnix, MD, PhD, The University of Texas MD Anderson Cancer Center
-
Christopher Pope, MD, Radiation Oncology Associates, PA
-
Kristin Redmond, MD, MPH, Johns Hopkins University
-
Sheila Rege, MD, Northwest Corporate Consulting LLC
-
Kilian Salerno, MD, National Cancer Institute, National Institutes of Health
-
Navesh Sharma, DO, PhD, WellSpan Radiation Oncology
-
Ke Sheng, PhD, University of California, San Francisco
-
Terence Sio, MD, Mayo Clinic Arizona
-
Abraham Wu, MD, Memorial Sloan Kettering Cancer Center
-
David Yu, MD, PhD, Emory University School of Medicine
Candidates for Fellow designation are nominated by current ASTRO Fellows, undergo rigorous peer review and are approved by ASTRO’s Board of Directors.
More information about the program is available online, including the complete list of ASTRO Fellows.

June 04, 2026 